Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to improve breathing tube decisions for tiniest preemies

NCT ID NCT06808997

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 15, 2026 · Updated 3 times

Summary

This study observes how doctors decide when to remove breathing tubes (extubation) in extremely preterm infants born before 28 weeks. Researchers will track 100 babies in the NICU, asking doctors daily why they choose to extubate or not. The goal is to understand current practices and improve future care for these fragile newborns.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors make better decisions about removing breathing tubes in preterm infants, potentially reducing lung damage and improving survival.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly change care. Results may not apply to all hospitals or infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

166 people

The number who actually took part.

Started

Feb 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participation in the study is proposed to type 3 neonatal intensive care units in France. Extremely premature newborns born before 28 weeks gestation in the participating units will be included.

Ages

1 minute to 5 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Gestational age \< 28 weeks of gestation * Age at admission to the participating unit \<24 hours Exclusion Criteria: * Parental opposition to their infant's clinical data collection * Participation in a research protocol with potential impact on extubation and/or duration of mechanical ventilation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bronchopulmonary dysplasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APHM_ Hôpital Nord

    Marseille, 13915, France

  • CH Cote Basque

    Bayonne, 64109, France

  • CH Estaing

    Clermont-Ferrand, 63 003, France

  • CH GHPSO

    Senlis, 60300, France

  • CH General Delafontaine

    Saint-Denis, 93205, France

  • CH Le Mans

    Le Mans, 72037, France

  • CH Orléans

    Orléans, 45067, France

  • CH Troyes

    Troyes, 10000, France

  • CHI Poissy - St Germain en LayE

    Poissy, 78303, France

  • CHIC

    Créteil, 94000, France

  • CHU Amiens Sud

    Amiens, 80054, France

  • CHU De Besancon

    Besançon, 25030, France

  • CHU Félix Guyon

    La Réunion, 97405, France

  • CHU Grenoble Alpes _site nord

    Grenoble, 38700, France

  • CHU Kremlin-Bicêtre

    Le Kremlin-Bicêtre, 94270, France

  • CHU Lille

    Lille, 75019, France

  • CHU NICE

    Nice, 06202, France

  • CHU Necker

    Paris, 75743, France

  • CHU Reims

    Reims, 51100, France

  • CHU Rennes

    Rennes, 35203, France

  • CHU Robert Debre

    Paris, 75019, France

  • Centre Hospitalier Public du Cotentin

    Cherbourg-Octeville, 50102, France

  • Chi Andre Gregoire

    Montreuil, 93105, France

  • Chu Louis Mourier

    Colombes, 92700, France

  • Chu Nimes

    Nîmes, 30000, France

  • Chu Port Royal

    Paris, 75679, France

  • Dr Jean-michel Roue

    Brest, 26609, France

  • GHEF- Site de MEAUX

    Meaux, 77104, France

  • GHRMSA-Hopital Emile Muller

    Mulhouse, 68100, France

  • HME Limoges

    Limoges, 87042, France

  • Hopital Femme Mére Enfant - HFME

    Bron, 69677, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.